Delivery Order SPE2DB20D2014-SPE2DB24FC78B
Award Date
8/16/24
Potential Completion Date
8/19/24
Potential Value
$78K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,154.18, is for the delivery of the medication Lupron Depot-Ped 11.25 mg 3 months, a treatment used in pediatric healthcare. The contract is a firm fixed-price delivery order with a completion date of March 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the pharmaceutical product Lupron Depot-Ped 11.25 mg 3-month injection, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $50,605.76 fixed-price delivery order contract has a completion date of January 30, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,934.32 firm fixed-price delivery order is for the supply of Lupron Depot-Ped 45 mg 6-month kits, a specialty pediatric medication. The contract has an ultimate completion date of December 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $80,903.54, is for the delivery of Lupron Depot-Ped 11.25 mg 3 months, a specialty medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of September 28, 2022. No set-aside requirements were designated for this award. AmerisourceBergen holds a significant...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the supply of Lupron Depot-Ped 30 mg 3-month kits to the Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC) is valued at up to $999,999,999.00 through December 31, 2025, and serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities worldwide in support of the Department of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,768.69 firm fixed-price delivery order is for the supply of Lupron Depot 11.25 mg 3-month kits, a specialty medication. The contract has an ultimate completion date of November 1, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lupron Depot-Ped 15 mg kits. The $11,029.35 firm fixed-price contract has an ultimate completion date of December 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which covers a comprehensive...
This federal contract award is for the delivery of LUPRON DEPOT-PED 11.25 MG 3MOS medication to the Defense Logistics Agency (DLA). The $86,491.75 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of September 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,779.73, is for the delivery of the medication Lupron Depot-Ped 11.25 mg with a completion date of May 28, 2024. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lupron Depot-Ped 11.25 mg 3-month medication, with a ceiling value of $54,741.55 and a completion date of July 25, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...